+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Darifenacin"

Darifenacin Hydrobromide Market in United States - Product Thumbnail Image

Darifenacin Hydrobromide Market in United States

  • Report
  • February 2026
  • 150 Pages
  • United States
From
Urinary Retention Therapeutics Market Report 2026 - Product Thumbnail Image

Urinary Retention Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Darifenacin Hydrobromide Market in Canada - Product Thumbnail Image

Darifenacin Hydrobromide Market in Canada

  • Report
  • February 2026
  • 150 Pages
  • Canada
From
Darifenacin Hydrobromide Market in China - Product Thumbnail Image

Darifenacin Hydrobromide Market in China

  • Report
  • February 2026
  • 150 Pages
  • China
From
Darifenacin Hydrobromide Market in Germany - Product Thumbnail Image

Darifenacin Hydrobromide Market in Germany

  • Report
  • February 2026
  • 150 Pages
  • Germany
From
Darifenacin Hydrobromide Market in India - Product Thumbnail Image

Darifenacin Hydrobromide Market in India

  • Report
  • February 2026
  • 150 Pages
  • India
From
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Darifenacin is a drug used to treat overactive bladder, a condition characterized by urinary urgency, frequency, and incontinence. It is a muscarinic receptor antagonist, meaning it works by blocking the action of acetylcholine, a neurotransmitter that causes bladder contractions. Darifenacin is available in both immediate-release and extended-release formulations. It is typically taken once daily, with or without food. Common side effects include dry mouth, constipation, and blurred vision. Darifenacin is used to treat a variety of urological disorders, including overactive bladder, urinary incontinence, and urinary retention. It is also used to reduce the risk of urinary tract infections. Darifenacin is available in generic and brand-name formulations. Several companies manufacture and market Darifenacin, including Astellas Pharma, Inc., Mylan Pharmaceuticals, Inc., and Teva Pharmaceuticals USA, Inc. Show Less Read more